Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.
about
Donepezil in Alzheimer's disease: From conventional trials to pharmacogeneticsFrom pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community.Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.Pharmacogenomics and therapeutic prospects in Alzheimer's disease.Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease.APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease.Genetics in clinical trials.Attitudes of health care professionals toward pharmacogenetic testing.Effects of transcutaneous electrical nerve stimulation (TENS) on self-efficacy and mood in elderly with mild cognitive impairment.Alzheimer's disease: diagnostics, prognostics and the road to prevention.Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients.Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.Suboptimal Baseline Serum Vitamin B12 Is Associated With Cognitive Decline in People With Alzheimer's Disease Undergoing Cholinesterase Inhibitor Treatment.
P2860
Q34965949-0C6692EC-970D-4879-B0C8-CAF73BCD620DQ35814384-72078D54-33A1-41BD-9155-9A3937E25590Q35852564-7C21A441-D1EC-4572-94CB-55CF9A1689CAQ36273420-7F7FFB81-81A5-4067-905E-650CB9A98810Q36475090-23BADB63-869D-4DAE-903C-690E5F7B21F9Q37031522-ABBC93F0-A04E-4E82-937D-120A8D066DBCQ37044205-322D0BD8-FAA1-488C-B58F-6D044BF2B28BQ37462565-9061F5C8-1887-4FC9-9D66-1E3FEC4A0898Q37881950-C209DACE-13AA-4233-9FB3-43892DB09614Q40482107-ECE58D8A-7C0C-4AE8-8B70-164E12BFDB18Q41731898-7F769313-6386-4608-9DF4-C77758682A84Q42644052-B42D2EF3-D379-402E-971F-118FD4105D1CQ46653039-F8A99389-8617-48D9-93C9-BDAA5449BA29Q54963522-207C12F4-7B58-4361-ACDE-A102F4352FD7
P2860
Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.
@en
Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.
@nl
type
label
Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.
@en
Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.
@nl
prefLabel
Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.
@en
Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.
@nl
P2093
P50
P356
P1476
Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.
@en
P2093
A Sandström
G Wachtmaister
H Olofsson
H Thostrup
I Karlsson
P2888
P304
P356
10.1007/S007020170066
P577
2001-01-01T00:00:00Z
P5875
P6179
1039646177